Begin animal studies for SP-26 ketamine implants
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 2 Jan 2025
- Due
- 30 Jun 2025
- Delivered
- by 7 Jan 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“animal testing is scheduled to begin in early 2025”
What we found
Evidence strength B What the grades mean
Silo Pharma launched non-GLP animal testing of SP-26 in December 2024, with implantation completed by early January 2025, well before the June 30, 2025 deadline.
-
B Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 Company press release confirming animal study start and January 2025 implantation
-
C Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 Confirms study launched Dec 2024; implantation completed first week of January 2025
-
D Silo Pharma's Investigational Ketamine Implant Hits All Endpoints In Pain Study In Animal Models Reports follow-up minipig study met all safety/efficacy endpoints
Checked 12 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Begin
- Language
- Firm (“will”, “on track to”)
How this entry was checked
- Commitment recordedRecorded from the company's filing.
- First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Silo Pharma, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-SILO-000003 · Corrections policy